Position in OCGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,172,979
New position
Shares Held
3,962,972
first reported quarter
Ownership
1.17%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ikarian Capital, LLC holds $559,248,616 across 106 Biotechnology names. OCGN ranks #31 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KOD |
Kodiak Sciences Inc.
|
1,265,795 | $48,252,105 | |
| 2 | ALMS |
Alumis Inc.
|
1,213,548 | $26,734,462 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
428,682 | $24,910,711 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
71,581 | $23,062,682 | |
| 5 | RLMD |
Relmada Therapeutics, Inc.
|
2,688,359 | $18,710,978 | |
| 6 | CYTK |
Cytokinetics Inc
|
283,572 | $18,690,230 | |
| 7 | TENX |
Tenax Therapeutics, Inc.
|
1,017,600 | $16,271,424 | |
| 8 | CAPR |
Capricor Therapeutics, Inc.
|
528,015 | $16,051,656 |
All Filings in OCGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,172,979 | 3,962,972 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||